Agape ATP Corp (ATPC) - Dilution Analysis

10-K filing | 1.0M shares outstanding

10-Q filing | 50.0M shares outstanding

10-Q filing | 50.0M shares outstanding

10-Q filing | 50.0M shares outstanding

S-1/A filing: The company entered into subscription agreements for the sale and issuance of 46,000,000 shares of common stock at $0.50 per share, resulting in gross proceeds of $23,000,000.

S-1 filing: Agape ATP Corporation is filing an S-1 to register the resale of up to 46,000,000 shares of common stock by selling stockholders.

10-K filing | 50.0M shares outstanding

8-K filing: Agape ATP Corporation closed a private placement on March 24, 2025, issuing 46,000,000 shares of common stock to non-U.S. investors at a price of US$0.50 per share for an aggregate purchase price of US$23,000,000. Following the issuance, the company had 50,005,381 shares of common stock issued and outstanding. ($23.0M proceeds)

8-K filing: Agape ATP Corporation entered into subscription agreements for the sale and issuance of 46,000,000 shares of common stock at $0.50 per share, resulting in gross proceeds of $23,000,000. ($23.0M proceeds)

10-Q filing | 3.9M shares outstanding

8-K filing: Stock split 1-for-20 | Outstanding: 76,969,691 → 3,848,484

10-Q filing | 77.0M shares outstanding

10-Q filing | 77.0M shares outstanding

10-K filing | 75.8M shares outstanding

10-Q filing | 75.5M shares outstanding

8-K filing: Agape ATP Corporation entered into an underwriting agreement with Network 1 Financial Securities, Inc. for an IPO of 1,650,000 shares of common stock at $4.00 per share. The IPO closed on October 13, 2023. ($6.6M proceeds)

S-1/A filing: Agape ATP Corporation is offering 1,650,000 shares of common stock in a firm commitment initial public offering, with an estimated initial public offering price of US$4.00 per share.

S-1/A filing: Agape ATP Corporation provides health solution advisory services to its clients, primarily focusing on attracting customers in Malaysia through its ATP Zeta Health Program, ÉNERGÉTIQUE, and BEAUNIQUE series.

10-Q filing | 75.5M shares outstanding

S-1/A filing: This S-1/A filing is for an initial public offering of 730,000 shares of common stock with an anticipated price between $5.50 and $6.50 per share, and includes an underwriter warrant for 7% of the shares sold.

10-Q filing | 75.5M shares outstanding

S-1/A filing: This is an S-1/A filing related to a purchase warrant for common stock issued to EF Hutton as part of an underwriting agreement.

S-1/A filing: This is a firm commitment initial public offering of 600,000 shares of common stock with an anticipated price between US$ 5.50 and US $6.50 per share.

10-K filing | 75.5M shares outstanding

S-1/A filing: This is a firm commitment initial public offering of 1,600,000 of our shares of common stock, $0.0001 par value per share.

10-Q filing | 75.5M shares outstanding

10-Q filing | 75.5M shares outstanding

10-Q filing | 75.5M shares outstanding

S-1/A filing: This is a firm commitment initial public offering of 7,700,000 shares of common stock with an anticipated price between US$ 5.50 and US $6.50 per share and includes a 15% over-allotment option for the Underwriter.

S-1/A filing: This is a filing for an initial public offering of common stock.

10-K filing | 75.5M shares outstanding

10-Q filing | 376.5M shares outstanding

10-Q filing | 376.5M shares outstanding

10-Q filing | 376.5M shares outstanding

10-K filing | 376.5M shares outstanding

10-Q filing | 376.5M shares outstanding

10-Q filing | 376.5M shares outstanding

S-1 filing: This is an S-1 filing for a firm commitment offering of common stock with an over-allotment option.

10-Q filing | 376.3M shares outstanding

10-K filing | 376.3M shares outstanding

8-K filing: Agape ATP Corporation's subsidiary sold 500,000 shares of Unreserved Sdn Bhd to Dato' Sri Dr. How Kok Choong for USD730,637. ($0.73M proceeds)